Platform for a tablet dispenser package insert
Latest Ortho Pharmaceutical Corporation Patents:
- Liquid phase peptide synthesis of KL-4 pulmonary surfactant
- Purification of antigen-specific T cells
- Liquid phase peptide syntheses of KL-4 pulmonary surfactant
- Methods and materials for modulation of the immunosuppresive activity and toxicity of monoclonal antibodies
- DNA encoding a human histamine receptor of the H3 subtype
Description
FIG. 1 is a perspective view of a platform for a tablet dispenser package insert as seen from top, front and left side showing our new design;
FIG. 2 is a top plan view thereof;
FIG. 3 is a bottom plan view thereof;
FIG. 4 is a front elevational view thereof;
FIG. 5 is a left side elevational view thereof, the right side elevational view being a mirror image thereof; and,
FIG. 6 is a rear elevational view thereof.
Referenced Cited
U.S. Patent Documents
D248407 | July 4, 1978 | Bassett et al. |
D272324 | January 24, 1984 | Mumford et al. |
D292380 | October 20, 1987 | Smith |
D298608 | November 22, 1988 | Dewing |
D339525 | September 21, 1993 | Morris, Sr. |
3651927 | March 1972 | Richardson et al. |
3904075 | September 1975 | Richardson et al. |
4015717 | April 5, 1977 | Richardson et al. |
4165709 | August 28, 1979 | Studer |
4555044 | November 26, 1985 | Pearo |
4905866 | March 6, 1990 | Bartell et al. |
5352465 | October 4, 1994 | Gondek et al. |
Patent History
Patent number: D372867
Type: Grant
Filed: Jul 29, 1994
Date of Patent: Aug 20, 1996
Assignee: Ortho Pharmaceutical Corporation (Raritan, NJ)
Inventor: Lawrence E. Lambelet, Jr. (Flemington, NJ)
Primary Examiner: Alan P. Douglas
Assistant Examiner: Robert M. Spear
Application Number: 0/26,511
Type: Grant
Filed: Jul 29, 1994
Date of Patent: Aug 20, 1996
Assignee: Ortho Pharmaceutical Corporation (Raritan, NJ)
Inventor: Lawrence E. Lambelet, Jr. (Flemington, NJ)
Primary Examiner: Alan P. Douglas
Assistant Examiner: Robert M. Spear
Application Number: 0/26,511
Classifications
Current U.S. Class:
D/9456